What to do when a GLP-1 shipment arrives warm
If an injectable medicine arrives warm, damaged or without clear instructions, contact the pharmacy before using it. The product and actual shipping conditions matter.
At a glance
- FDA warns against using injectable GLP-1 drugs arriving warm or with insufficient refrigeration.
- Photograph the package and record delivery timing for the pharmacy.
- Do not try to restore a questionable medicine by freezing it.
Inspect the shipment before the first dose
Check the medicine name, pharmacy identification, packaging, instructions and temperature-control materials. A product that differs from the expected shipment should be clarified rather than used on the assumption that it is equivalent.
FDA’s current unapproved-GLP-1 guidance addresses poor refrigeration, fraudulent pharmacy labeling and product quality. A discount does not compensate for an unresolved quality concern.
Sources: FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss Wegovy prescribing informationZepbound prescribing information
Get a product-specific answer
Ask the pharmacist what is known about the shipment, whether the medicine may be used under the product’s label and whether a replacement is required. Keep the package available while the issue is reviewed.
If a dose will be missed, ask the prescriber or pharmacist about the instructions for that exact medicine. Do not take extra medication when a replacement arrives.
Sources: FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss Wegovy prescribing informationZepbound prescribing information
Sources and review boundaries
Source check dates are listed below. First-party pages support descriptions of a service’s public offer; medical references support the educational context. They do not establish an independent clinical audit of a provider. This is general education, not personal medical advice; no named licensed clinical reviewer has reviewed this article.
- FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss Medical or regulatory source · Source reviewed ·
- Wegovy prescribing informationMedical or regulatory source · Source reviewed ·
- Zepbound prescribing informationMedical or regulatory source · Source reviewed ·
Related Articles
- GLP-1 medicines before surgery: what to tell the anesthesia team
- Alcohol on semaglutide: risks and questions for your prescriber
- Alcohol on tirzepatide: risks and questions for your prescriber
- Semaglutide compounding pharmacies: sourcing, rules and open questions
- Tirzepatide compounding pharmacies: sourcing, rules and open questions
- Choosing Alternatives If You Cannot Take a GLP-1
By Chief Medical Correspondent. Published . Updates are recorded when content changes.